Results 241 to 250 of about 4,637,377 (303)

Threonine 348 regulates the subcellular localization of PTEN

FEBS Open Bio, EarlyView.
Thr348 in the C2 domain is a key contributor to PTEN subcellular localization. The PTEN350 fragment and PTENA4 accumulated in the nucleus, whereas PTENK13R,A4 predominantly localized to the plasma membrane. In contrast, substitution of Thr348 with Asp (T348D) disrupted these characteristic localization patterns, resulting in predominant cytoplasmic ...
Takashi Kato, Suzu Tanaka, Miyu Ohashi
wiley   +1 more source

Supportive care needs as an independent risk factor for survival in advanced liver cancer: a prospective cohort study. [PDF]

Front Oncol
Liao X, Liao D, Lin H, Chen H.
europepmc   +1 more source

Supportive Care for HDR Brachytherapy in Gynecological Cancer: A Single Center Experience. [PDF]

In Vivo
Meinecke D, Bruns F, Christiansen H, Steinkasserer L, Knöchelmann AC.   +4 more
europepmc   +1 more source

Nutritional Management in Patients With Hematological Malignancies: An Underestimated Supportive Care Issue. [PDF]

Cureus
El Ouafa Y, Fadi M, Benrahma H, Bouanani N.   +3 more
europepmc   +1 more source

Glycolytic reprogramming in cancer: immune crosstalk, nutrient competition, and supportive care perspectives. [PDF]

Front Immunol
Wu H, Wang Y, Tian Y, Feng S, Yang X, Yuan X, Fan L, Feng Q, Liu Z, Zhao Q.   +9 more
europepmc   +1 more source

Utilization of Non-pharmacological Interventions in Rett Syndrome: A Systematic Review of the Literature on Supportive Care Management. [PDF]

Neurol Ther
Rashid N, Syed SS, Rajagopalan K, Yakkala VK, Sikirica M, Yunusa I.   +5 more
europepmc   +1 more source

The supportive care needs of Iranian couples during postpartum hospitalization: A protocol of design, implementation and evaluation of intervention. [PDF]

PLoS One
Rastad Z, Sighaldeh SS, Moghadam ZB, Siahkal SF, Ebrahimi E.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Supportive Care

Hematology, 2004
Abstract To optimize treatment outcomes for hematologic malignancies, minimizing the consequences of treatment complications requires as much skill as the choice of the treatment itself. Myelosuppression and immunosuppression are frequent complications and have potentially serious infectious consequences.
John R, Wingard, W Garrett, Nichols, George B, McDonald   +2 more
openaire   +3 more sources